drugset / Trial / NCT02211911

Pharmacokinetics of Bisacodyl or Sodium Picosulfate Administered Orally in Healthy Lactating Females

NCT02211911

Phase 1 Completed 16 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelTreatment

Summary

To investigate if bisacodyl (Dulcolax®) and sodium picosulfate (Laxoberal®) is excreted in breast milk of healthy lactating women after an oral administration of 10 mg once daily over a period of 8 days.

Timeline

Start
2008-02
Primary completion
2008-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Bisacodyl Small molecule 10 mg Oral
Subject Sodium Picosulfate Unknown 10 mg Oral

Indications

No indication recorded.